2011
DOI: 10.3171/2010.9.jns10445
|View full text |Cite
|
Sign up to set email alerts
|

Risk of ventriculostomy-related hemorrhage in patients with acutely ruptured aneurysms treated using stent-assisted coiling

Abstract: The application of dual antiplatelet therapy in stent-assisted coiling of acutely ruptured aneurysms is associated with an increase in the risk of hemorrhagic complications following ventriculostomy or VP shunt placement, as compared with its use in a coiling procedure without a stent.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
79
0
1

Year Published

2012
2012
2023
2023

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 135 publications
(83 citation statements)
references
References 29 publications
3
79
0
1
Order By: Relevance
“…However, this can complicate the inpatient management of attendant procedures for patients with SAH, especially EVD placement and removal, shunt placement, and decompressive craniectomy. Ventriculoperitoneal shunt-related ICH rates of up to 71% have been reported in patients concomitantly treated with dual antiplatelet agents after stent-assisted aneurysm coiling, 13,18 and a significantly increased risk of fatal hemorrhagic complications was reported with respect to dual antiplatelet therapy during stent-assisted aneurysm coiling by Mocco et al, who found a 12% risk of mortality in an SAH cohort relative to a 0.8% mortality in the unruptured aneurysm cohort. 21 All previously reported blister aneurysm flow-diversion treatment series described dual antiplatelet pretreatment prior to flow-diverter placement; similarly, all patients in our series also underwent preloading with aspirin and clopidogrel.…”
Section: Discussionmentioning
confidence: 99%
“…However, this can complicate the inpatient management of attendant procedures for patients with SAH, especially EVD placement and removal, shunt placement, and decompressive craniectomy. Ventriculoperitoneal shunt-related ICH rates of up to 71% have been reported in patients concomitantly treated with dual antiplatelet agents after stent-assisted aneurysm coiling, 13,18 and a significantly increased risk of fatal hemorrhagic complications was reported with respect to dual antiplatelet therapy during stent-assisted aneurysm coiling by Mocco et al, who found a 12% risk of mortality in an SAH cohort relative to a 0.8% mortality in the unruptured aneurysm cohort. 21 All previously reported blister aneurysm flow-diversion treatment series described dual antiplatelet pretreatment prior to flow-diverter placement; similarly, all patients in our series also underwent preloading with aspirin and clopidogrel.…”
Section: Discussionmentioning
confidence: 99%
“…The risk of ventriculostomy-related hemorrhage is higher in patients with SAH treated with stent-assisted coiling than in those with coiling without a stent. 26 In this study, an EVD was placed in 10 of 40 patients, with ventriculostomy-related hemorrhage occurring in 2 of 5 patients whose EVD was placed before coiling. The hemorrhage was characterized by small petechial bleeding along the catheter tract, which was Ͻ1 cm in diameter, asymptomatic, and temporary.…”
Section: -12mentioning
confidence: 99%
“…9 Contrary to a series by Almekhlafi et al, 9 we did not use antiplatelet therapy; thus theoretically reducing the risk of hemorrhagic complications linked to intraprocedural rupture of the aneurysm and to subsequent surgical interventions to treat intracranial hypertension such as EVD placement or decompressive craniectomy. 16 In our series, 4 of the 8 patients underwent emergent EVD placement, and no hemorrhagic complication was noted. Moreover, 1 patient had an intraoperative aneurysm rupture that was successfully managed by coil packing.…”
Section: Discussionmentioning
confidence: 58%